Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?
- 31 December 1995
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 31 (4), 510-515
- https://doi.org/10.1016/0959-8049(95)00044-j
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastomaMedical and Pediatric Oncology, 1995
- Molecular Basis of Clinical Heterogeneity in NeuroblastomaJournal of Pediatric Hematology/Oncology, 1992
- Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.Journal of Clinical Oncology, 1991
- Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1Cancer, 1989
- Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastomaBritish Journal of Cancer, 1988
- Chromosome localization in normal human cells and neuroblastomas of a gene related to c-mycNature, 1984
- Abnormalities of chromosome 1p in human neuroblastoma tumors and cell linesCancer Genetics and Cytogenetics, 1982
- Stage II neuroblastoma. Adverse prognostic significance of lymph node involvement.Archives of Disease in Childhood, 1982
- SPECIAL PATTERN OF WIDESPREAD NEUROBLASTOMA WITH A FAVOURABLE PROGNOSISThe Lancet, 1971
- A proposed staging for children with neuroblastoma.Children's cancer study group ACancer, 1971